John Deakin-Bell
Stock Analyst at Citigroup
(0.37)
# 4,157
Out of 4,979 analysts
3
Total ratings
33.33%
Success rate
-11.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Deakin-Bell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Upgrades: Buy | n/a | $279.19 | - | 3 | Sep 8, 2022 |
ResMed
Sep 8, 2022
Upgrades: Buy
Price Target: n/a
Current: $279.19
Upside: -